Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI [NA]
Georgetown University is recruiting for a study evaluating a multilevel decision-support intervention to guide breast MRI screening for brea…
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: MRI in Assessing Tumor Size in Women With Ductal Carcinoma In Situ [NA]
A completed clinical trial evaluating the use of MRI to measure tumor size in women with ductal carcinoma in situ (DCIS) of the breast.
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: Study of Metabolites Markers in Adjuvant Breast Cancer
A completed clinical trial evaluating metabolite markers in the adjuvant setting for breast cancer to identify potential prognostic or predi…
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: Web-based Intervention for Long-term Breast Cancer Survivors [NA]
This entry describes a web-based intervention trial for long-term breast cancer survivors. The study is currently recruiting to address long…
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: Immune Adverse Events Registry in Onco-Hematologic Patients Treated With Immunotherapy
A registry study tracking immune-related adverse events in cancer patients receiving immunotherapy. The study is not yet recruiting and is s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: Study of AC699 in Patients With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Locally Advanced or Metastatic Breast Cancer [Phase 1]
Phase 1 clinical trial of AC699 in ER+/HER2- locally advanced or metastatic breast cancer is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: REduction of Physical Inactivity Facing the CAncer [NA]
This clinical trial update confirms the completion of a study focused on reducing physical inactivity among breast cancer patients.
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: MELIORA Data Collection Campaigns [NA]
This is a status update for the MELIORA data collection campaigns; the study is currently recruiting for breast cancer prevention.
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: Study of Cardiopulmonary Exercise Testing in Women Who Have HER2-Positive Breast Cancer With Mild Cardiotoxicity
An update on a study evaluating cardiopulmonary exercise testing in women with HER2-positive breast cancer who have mild cardiotoxicity; the…
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: A Phase II Exploratory Study of Iparomlimab and Tuvonralimab Combined With Chemotherapy in Neoadjuvant Treatment of HR+/HER2- Breast Cancer Patients [Phase 2]
Phase II exploratory neoadjuvant trial evaluating the combination of Iparomlimab and Tuvonralimab with chemotherapy in HR+/HER2- breast canc…
-
CLINICAL_TRIALS trial_result · 2025-09-29Clinical Trial Update: Evaluating the Effectiveness of an Individualized Nutrition and Physical Activity Counseling Program [NA]
A completed clinical trial assessed the effectiveness of an individualized nutrition and physical activity counseling program for individual…
-
CLINICAL_TRIALS trial_result · 2025-09-29Clinical Trial Update: PECTORAL PLANE BLOCK COMPAIRED TO ERECTOR SPINAE PLANE BLOCK IN MULTIMODAL ANALGESIA FOR MASTECTOMY PATIENTS IN SOUTH ASIAN POPULATION -A PROSPECTIVE RANDOMISED CONTROL TRIAL [NA]
A prospective randomized controlled trial comparing pectoral plane block to erector spinae plane block for multimodal analgesia in mastectom…
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: AKT Inhibitor, Ipatasertib, With Endocrine and CDK 4/6 Inhibitor for Patients With Metastatic Breast Cancer (TAKTIC) [Phase 1]
A Phase 1 trial update evaluating the AKT inhibitor ipatasertib in combination with endocrine therapy and a CDK4/6 inhibitor for metastatic …
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: Adjuvant Abemaciclib for Locoregional Recurrence of HR-positive, HER2-negative Breast Cancer (JCOG2313, AURA) [Phase 3]
A Phase 3 trial (NCT07190443) is evaluating adjuvant abemaciclib for locoregional recurrence in HR-positive, HER2-negative breast cancer; re…
-
CLINICAL_TRIALS trial_result · 2025-09-29Clinical Trial Update: A Study to Compare Eribulin Mesylate + Pertuzumab + Trastuzumab With Paclitaxel or Docetaxel + Pertuzumab + Trastuzumab [Phase 3]
A Phase 3 breast cancer trial comparing eribulin mesylate + pertuzumab + trastuzumab versus paclitaxel or docetaxel + pertuzumab + trastuzum…
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study [Phase 2]
This clinical trial update describes a Phase 2 long-term treatment extension study of niraparib for participants who completed a prior GSK/T…
-
CLINICAL_TRIALS trial_result · 2025-09-29Clinical Trial Update: Impact of Topical Tranexamic Acid in Breast Reconstruction [Phase 4]
A Phase 4 trial evaluating topical tranexamic acid to reduce bleeding in breast reconstruction was terminated, and results have been posted.
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: Testing a Mammography Decision Intervention in a Rural Setting [NA]
A clinical trial is testing a mammography decision intervention to support screening decisions in a rural setting. Recruitment is ongoing.
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: Sacituzumab Govitecan and Intrathecal Chemotherapy for Treating Leptomeningeal Metastases From Her2-negative Breast Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial assessing Sacituzumab Govitecan in combination with intrathecal chemotherapy for leptomeningeal metastases from H…
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: Phase II Multi-center Trial Evaluating 5 Fraction Stereotactic Partial Breast Irradiation Using Gammapod [NA]
This document provides an update on a Phase II multi-center trial evaluating 5-fraction stereotactic partial breast irradiation using Gammap…
-
CLINICAL_TRIALS trial_result · 2025-09-29Clinical Trial Update: Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer Survivors [NA]
A clinical trial evaluating exercise to target metabolic dysregulation in stage I-III breast and prostate cancer survivors has been terminat…
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: Comparison of Outcomes of Right Internal Jugular Port Implantation in Patients With Right Versus Left Breast Cancer Undergoing Chemotherapy
This clinical trial compares outcomes of right vs left internal jugular Port-A-Cath implantation in patients with breast cancer undergoing c…
-
CLINICAL_TRIALS trial_result · 2025-09-26Clinical Trial Update: Abemaciclib in Combination With Endocrine Therapy as First Line Therapy in Metastatic Breast Cancer Patients
ClinicalTrials.gov indicates a completed study evaluating abemaciclib in combination with endocrine therapy as first-line treatment for meta…
-
CLINICAL_TRIALS research · 2025-09-26Clinical Trial Update: A Study of SI-B003 or BL-B01D1+SI-B003 in Patients With Unresectable Locally Advanced or Recurrent Metastatic HER2 Negative Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating SI-B003 alone or in combination with BL-B01D1 for unresectable locally advanced or recurrent metastatic HE…
-
CLINICAL_TRIALS other · 2025-09-26Clinical Trial Update: A Study of GNC-035, a Tetra-specific Antibody, in Participants With Locally Advanced or Metastatic Breast Cancer [Phase 1]
Phase 1 clinical trial update for GNC-035, a tetra-specific antibody, in breast cancer; the study is currently ACTIVE_NOT_RECRUITING.